Leal Justin, Wu Christine J, Seyler Thorsten M, Jiranek William A, Wellman Samuel S, Bolognesi Michael P, Ryan Sean P
Department of Orthopaedic Surgery, Duke University, Durham, North Carolina.
J Arthroplasty. 2025 May;40(5):1326-1334.e3. doi: 10.1016/j.arth.2024.10.102. Epub 2024 Oct 30.
This study aimed to describe the management and outcomes of aseptic revision total hip arthroplasty (arTHA) with unsuspected intraoperative positive cultures (UPCs) compared to those with sterile cultures.
A single tertiary center's institutional database was retrospectively reviewed for arTHA from January 2013 to October 2023. Preoperative Musculoskeletal Infection Society scores were assigned to patients based on available infectious workup, and those who met the criteria for periprosthetic joint infection (PJI), received antibiotic spacers, or had less than 1-year follow-up were excluded. Patients were grouped and compared according to intraoperative culture results as follows: sterile cultures, one unexpected positive culture with a new organism, one UPC with the same organism as prior PJI, ≥ two UPCs with different organisms, and ≥ 2 UPCs with the same organism.
There was a total of 604 arTHAs included in this study, of which 0.8% [5 of 604] had ≥ two UPCs with different organisms, 1.5% [9 of 604] had ≥ two UPCs with the same organism, 9.8% [59 of 604] had one UPC with a new organism, 0.2% [one of 604] had one UPC with an organism from prior PJI, and 87.7% [530 of 604] of patients had sterile cultures. When comparing 5-year infection-free survival between patients who had one UPC with a new organism and sterile cultures, there was no difference (P = 0.40); however, patients who had ≥ two UPCs with different organisms (P < 0.001), patients who had ≥ two UPCs with the same organism (P = 0.001), and patients who had one UPC of an organism from prior PJI (P < 0.001) had statistically worse infection-free survival compared to patients with sterile cultures.
Infection-free survival at five years was similar between patients who had one UPC with a new organism and those who had sterile cultures; however, ≥ two UPCs and a history of PJI are both significant risk factors for rerevision for infection after arTHA.
本研究旨在描述与无菌培养相比,术中未怀疑有阳性培养结果(UPC)的无菌性翻修全髋关节置换术(arTHA)的管理及结果。
回顾性分析单个三级中心2013年1月至2023年10月期间arTHA的机构数据库。根据可用的感染检查结果为患者分配术前肌肉骨骼感染学会评分,排除符合假体周围关节感染(PJI)标准、接受抗生素间隔物治疗或随访时间少于1年的患者。根据术中培养结果将患者分组并进行比较,如下:无菌培养、一种新微生物的意外阳性培养、与先前PJI相同微生物的一次UPC、≥两种不同微生物的UPC以及≥两种相同微生物的UPC。
本研究共纳入604例arTHA,其中0.8%[604例中的5例]有≥两种不同微生物的UPC,1.5%[604例中的9例]有≥两种相同微生物的UPC,9.8%[604例中的59例]有一次新微生物的UPC,0.2%[604例中的1例]有一次来自先前PJI的微生物的UPC,87.7%[604例中的530例]患者为无菌培养。比较有一次新微生物UPC的患者和无菌培养患者的5年无感染生存率,无差异(P = 0.40);然而,与无菌培养患者相比,有≥两种不同微生物UPC的患者(P < 0.001)、有≥两种相同微生物UPC的患者(P = 0.001)以及有一次来自先前PJI的微生物UPC的患者(P < 0.001)的无感染生存率在统计学上更差。
有一次新微生物UPC的患者和无菌培养患者的5年无感染生存率相似;然而,≥两次UPC和PJI病史都是arTHA术后因感染再次翻修的重要危险因素。